Search results
MacroGenics reports progress in prostate cancer study By Investing.com
Investing.com· 11 hours agoThe study investigates vobra duo, an antibody-drug conjugate (ADC), in patients with metastatic...
O.J. Simpson died from prostate cancer, not COVID-19 vaccine | Fact check
USA TODAY via Yahoo News· 7 days agoA television news outlet in Florida reported in February, about two months before Simpson's death, that he had been diagnosed with prostate cancer. A statement released by ...
...Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across...
Digital Journal· 4 days ago“The TACT 5-year clinical trial data, along with multiple real-world reports on the safety, efficacy and durability of TULSA from U...
Earnings call: Veracyte sees robust growth driven by diagnostics platform By Investing.com
Investing.com· 2 days agoThe company's revenue reached $96.8 million, marking a 17% increase from the same period last year,...
Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical...
St. Louis Post-Dispatch· 7 days agoJohnson & Johnson announced today results from the open-label, single-arm Phase 2 Apa-RP study evaluating adjuvant treatment with ERLEADA® (apalutamide) and androgen deprivation therapy (ADT ...
Earnings call: FibroGen reports Q1 2024 results, optimistic about pipeline By Investing.com
Investing.com· 3 days agoThe company highlighted the upcoming top line data from Phase 3 studies for pamrevlumab in...
Johnson & Johnson Advances Its Two Bladder Cancer Studies, Releases Latest Data
Benzinga via Yahoo Finance· 4 days agoOn Sunday, Johnson & Johnson (NYSE:JNJ) ) released updated results from an open-label, multicenter,...
Dr. Roach: Brown semen usually doesn't present a health concern
St. Louis Post-Dispatch· 1 day agoDr. Roach: I am an 85-year-old male. Other than being a Type 2 diabetic, I am still active and in good health. I do have a concern; on the rare
Obesity, poor diet & physical inactivity driving early onset of cancers: Health expert
Investing.com· 6 days agoNew Delhi, May 4 (IANS) Obesity, poor diet, and physical inactivity are driving the onset of several...
Citi cuts ORIC Pharmaceuticals stock price target post 1Q24 pipeline update By Investing.com
Investing.com· 3 days agoORIC Pharmaceuticals is set to begin combination trials for its drug candidate, ORIC-944, a PRC2...